» Articles » PMID: 31243882

Difference in 24-hour Urine Sodium Excretion Between Controlled and Uncontrolled Patients on Antihypertensive Drug Treatment

Overview
Date 2019 Jun 28
PMID 31243882
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

The objective of this study was to evaluate the association between sodium intake and blood pressure (BP) control in hypertensive patients taking antihypertensive medications by using 24-hour urine collection and 24-hour ambulatory BP. This is a cross-sectional community-based study and conducted in 2011 and 2012. A total of 1128 participants were recruited from five cities in Korea. Among them, 740 participants who had complete 24-hour urine collection and valid 24-hour ambulatory BP data were included in this study. Participants were divided into four groups: normotensives (NT, n = 441), untreated hypertensive patients (UTHT, n = 174), controlled hypertensive patients (CHT, n = 62), and uncontrolled hypertensive patients (UCHT, n = 63). UCHT and CHT groups showed higher mean age than NT and UTHT groups. UCHT and UTHT groups showed higher 24-hour systolic BP (SBP) and diastolic BP (DBP) than NT and CHT groups. UCHT group had the highest level of 24-hour urine sodium. Multivariate analysis adjusted with age, gender, body mass index, estimated glomerular filtration rate, and use of diuretics showed higher level of 24-hour urine sodium in UCHT group than that in CHT group. Multivariate logistic regression analysis revealed independent association of the amount of 24-hour urine sodium with uncontrolled BP in hypertensive patients on antihypertensive drug treatment. Higher level of 24-hour urine sodium excretion in uncontrolled hypertensive patients suggests that excessive sodium intake could be associated with blunted BP lowering efficacy of antihypertensive medications.

Citing Articles

Urine Cell Transcriptomes Implicate Specific Renal Inflammatory Pathways Associated With Difficult-to-Control Hypertension.

Umanath K, She R, Hassett C, Adrianto I, Levin A, Savickas G J Am Heart Assoc. 2023; 12(6):e026242.

PMID: 36892045 PMC: 10111524. DOI: 10.1161/JAHA.122.026242.


Prevalence and characteristics of isolated nocturnal hypertension in the general population.

Rhee M, Kim J, Kim C, Kim J, Lee J, Kim S Korean J Intern Med. 2021; 36(5):1126-1133.

PMID: 34503319 PMC: 8435498. DOI: 10.3904/kjim.2021.022.


Further evidence that methods based on spot urine samples should not be used to examine sodium-disease relationships from the Science of Salt: A regularly updated systematic review of salt and health outcomes (November 2018 to August 2019).

Petersen K, Malta D, Rae S, Dash S, Webster J, McLean R J Clin Hypertens (Greenwich). 2020; 22(10):1741-1753.

PMID: 32964622 PMC: 8029798. DOI: 10.1111/jch.13958.


Dietary Sodium Intake and Health Indicators: A Systematic Review of Published Literature between January 2015 and December 2019.

Overwyk K, Quader Z, Maalouf J, Bates M, Webster J, George M Adv Nutr. 2020; 11(5):1174-1200.

PMID: 32449929 PMC: 7490163. DOI: 10.1093/advances/nmaa049.


Sodium Intake Reduction in Real World.

Rhee M Korean Circ J. 2020; 50(5):441-442.

PMID: 32153147 PMC: 7098820. DOI: 10.4070/kcj.2020.0053.


References
1.
Wei W, Tolle M, Zidek W, van der Giet M . Validation of the mobil-O-Graph: 24 h-blood pressure measurement device. Blood Press Monit. 2010; 15(4):225-8. DOI: 10.1097/MBP.0b013e328338892f. View

2.
Knuiman J, Hautvast J, Van der Heyden L, Geboers J, JOOSSENS J, Tornqvist H . A multi-centre study on completeness of urine collection in 11 European centres. I. Some problems with the use of creatinine and 4-aminobenzoic acid as markers of the completeness of collection. Hum Nutr Clin Nutr. 1986; 40(3):229-37. View

3.
Luft F, Morris C, Weinberger M . Compliance to a low-salt diet. Am J Clin Nutr. 1997; 65(2 Suppl):698S-703S. DOI: 10.1093/ajcn/65.2.698S. View

4.
Weir M, Chrysant S, McCarron D, Cohen J, Gunter P, Lewin A . Influence of race and dietary salt on the antihypertensive efficacy of an angiotensin-converting enzyme inhibitor or a calcium channel antagonist in salt-sensitive hypertensives. Hypertension. 1998; 31(5):1088-96. DOI: 10.1161/01.hyp.31.5.1088. View

5.
Azizi M, Blanchard A, Charbit B, Wuerzner G, Peyrard S, Ezan E . Effect of contrasted sodium diets on the pharmacokinetics and pharmacodynamic effects of renin-angiotensin system blockers. Hypertension. 2013; 61(6):1239-45. DOI: 10.1161/HYPERTENSIONAHA.113.01196. View